Epirubicin, Docetaxel, and Capecitabine in Treating Women With Stage IIIA or Stage IIIB Breast Cancer
Clinical trial NCT00645866 · COMPLETED
Trial details
- NCT number
- NCT00645866
- Sponsor
- Mayo Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-04-01
- Primary completion
- 2006-03-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.